Profil

Thissen Benedicte

See author's contact details
Main Referenced Co-authors
Deneufbourg, Jean-Marie  (4)
Jansen, Nicolas  (4)
Nickers, Philippe  (4)
Coucke, Philippe  (1)
Hermesse, Johanne  (1)
Main Referenced Keywords
prostate (4); brachytherapie (2); HDR (2); 192 Iridium (1); boost (1);
Main Referenced Disciplines
Oncology (5)
Radiology, nuclear medicine & imaging (3)

Publications (total 5)

The most downloaded
122 downloads
Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (January 2006). 192-Ir or 125-I Prostate Brachytherapy as a Boost to External Beam Radiotherapy in Locally Advanced Prostatic Cancer: A Dosimetric Point of View. Radiotherapy and Oncology, 78 (1), 47-52. doi:10.1016/j.radonc.2005.09.002 https://hdl.handle.net/2268/3697

The most cited

22 citations (OpenCitations)

Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (January 2006). 192-Ir or 125-I Prostate Brachytherapy as a Boost to External Beam Radiotherapy in Locally Advanced Prostatic Cancer: A Dosimetric Point of View. Radiotherapy and Oncology, 78 (1), 47-52. doi:10.1016/j.radonc.2005.09.002 https://hdl.handle.net/2268/3697

Hermesse, J., Thissen, B., Warlimont, B., Jansen, N., Coucke, P., & Niockers, P. (2008). Analysis of Dose Volume Histogram Differences between High Dose Rate Brachytherapy and Intensity Modulated Radiotherapy for Prostate Treatment. International Journal of Radiation, Oncology, Biology, Physics, 72 (1 (supplément)), 566. doi:10.1016/j.ijrobp.2008.06.140
Peer Reviewed verified by ORBi

Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (January 2006). 192-Ir or 125-I Prostate Brachytherapy as a Boost to External Beam Radiotherapy in Locally Advanced Prostatic Cancer: A Dosimetric Point of View. Radiotherapy and Oncology, 78 (1), 47-52. doi:10.1016/j.radonc.2005.09.002
Peer Reviewed verified by ORBi

Nickers, P., Lenaerts, E., Thissen, B., & Deneufbourg, J.-M. (February 2005). Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system? Radiotherapy and Oncology, 74 (2), 131-136. doi:10.1016/j.radonc.2004.10.013
Peer Reviewed verified by ORBi

Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (October 2004). 192lr LDR brachytherapy(BT) is at least as efficient as HDR options for boosting unfavourable prostate cancers after EBRT. Proposals for future prospects. Radiotherapy and Oncology, 73 (Suppl. 1), 83.
Peer Reviewed verified by ORBi

Nickers, P., Jansen, N., Thissen, B., & Deneufbourg, J.-M. (May 2004). 192Ir LDR Brachytherapy(BT) is at least as efficient as HDR options for boosting intermediate or unfavourable prostate cancers after EBRT. Experience on 201 patients. Radiotherapy and Oncology, 71 (Suppl. 2), 124-S125.
Peer Reviewed verified by ORBi

Contact ORBi